Digital Pathology Market

The market for digital pathology is expected to grow at a CAGR of 13.2% from 2021 to 2026, from an estimated value of USD 736 million in 2021 to USD 1,371 million. The use of digital pathology to improve lab efficiency, the rising cancer incidence, and the expanding use of digital pathology in drug development and companion diagnostics are the primary drivers of market expansion.

Increasing Adoption Of Digital Pathology To Enhance Lab Efficiency

The global market for digital pathology is expected to rise as a result of the COVID-19 epidemic. The U.S. FDA’s Center for Devices and Radiological Health published an enforcement guideline for remote digital pathology devices that are used by pathologists, clinical lab workers, and personnel from the drug administration. As a result, the prevalence of chronic diseases has raised the use of digital pathology systems for diagnosis, which is expected to fuel the growth of the global market for digital pathology over the coming years.

Digital Pathology Market Segmentation

Type, application, end user, and region are the market segments used to divide the digital pathology industry. The market is divided into three types based on type: scanners, software, and storage & communication systems.

Applications include teleconsultation, disease diagnostics, drug research, training & education, and so on Based on the end user, it is separated into educational, clinical, and pharma & biotech enterprises.

Top Digital Pathology Companies

Leica Biosystems

Koninklijke Philips N.V.

Hamamatsu Photonics



Huron Digital Pathology

Visiopharm A/S

Inspirata, Inc.


Kanteron Systems


Geographies Adoption Of Digital Pathology

North America


Asia Pacific

Latin America

Middle East


Submit Abstract

Recommended Articles

Leave a Reply

Your email address will not be published. Required fields are marked *